Efektivitas Lactobacillus plantarum terhadap Serum Imunoglobulin E Total dan Indeks Scoring Atopic Dermatitis (SCORAD) Pasien Dermatitis Atopik Dewasa
Downloads
Latar Belakang: Dermatitis Atopik (DA) dapat disebabkan oleh ketidakseimbangan sel T-helper (Th) 1 dan Th2 yang diduga memengaruhi kadar imunoglobulin (Ig) E, yang juga memengaruhi indeks Scoring Atopic Dermatitis (SCORAD). Studi mengenai efek terapi probiotik pada DA telah dilakukan, namun hanya sedikit dilakukan pada dewasa dan hasilnya bervariasi. Lactobacillus plantarum IS-10506 (LP IS-10506) adalah probiotik indigenous asal Indonesia yang telah diuji secara in vitro maupun in vivo. Tujuan: Mengevaluasi efek terapi probiotik LP IS-10506 terhadap serum Ig E total dan indeks SCORAD dalam pengobatan DA. Metode: Uji klinis acak terkontrol tersamar ganda terhadap 30 pasien, dilakukan randomisasi untuk mendapatkan probiotik atau plasebo selama 8 minggu. Kadar serum Ig E total dan indeks SCORAD dievaluasi sebelum dan sesudah intervensi. Hasil: Lima belas subjek kelompok probiotik dan 15 subjek kelompok plasebo telah menyelesaikan studi. Tidak didapatkan perbedaan bermakna rerata kadar Ig E total kelompok probiotik dan plasebo pada akhir studi, masing-masing 470,833 + 751,329 IU/ml dan 222,826 + 181,681 IU/ml (p=0,350). Rerata penurunan indeks SCORAD pada kelompok probiotik lebih besar dibandingkan plasebo dengan perbedaan bermakna pada akhir studi, masing-masing 9,6133 + 2,552 dan 13,133 + 5,029 (p= 0,022). Simpulan: Tidak didapatkan perbedaan bermakna pemberian probiotik dalam hal penurunan kadar serum Ig E total dibandingkan kelompok kontrol. Penurunan indeks SCORAD bermakna pada kelompok probiotik dibandingkan kelompok kontrol.
Leung DYM, Eichenfield LF, Boguniewicz M. Atopic dermatitis (Atopic eczema). In: Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K, editors. Fitzpatrick's dermatology in general medicine. 8th ed. New York: McGraw-Hill; 2012. p.165-82.
Blome C, Radtke A, Eissing L, Augustin M. Quality of life in patients with atopic dermatitis: disease burden, measurement, and treatment benefit. Am J Clin Dermatol 2016;17(2):163-9.
Gerasimov S, Vasjuta V, Myhovych O, Bondarchuk L. Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Of Clin Derm 2012;11: 351-61.
Rahman S, Collins M, Williams C, Ma H. The pathology and immunology of atopic dermatitis. Inflamm Alergy Drug Targets 2011; 10(6):
Chang YS, Trivedi MK, Jha A, Lin YF, Dimaano L, García-Romero MT. Synbiotics for prevention and treatment of atopic dermatitis: a meta-analysis of randomized clinical trials. JAMA Pediatr 2016;170(3):236-42.
Roekevisch E, Spuls PI, Kuester D, Limpens J, Schmitt J. Efficacy and safety of systemic treatments for moderate-to-severe atopic dermatitis: a systematic review. J Allergy Clin Immunol 2014;133(2):429-38.
Pandey K, Naik S, Vakil B. Probiotics, prebiotics and synbiotics- a review. J Food Sci Technol 2015; 52(12):7577–87.
Kim SO, Ah YM, Yu YM, Choi KY, Shin WG, Lee JY. Effects of probiotics for the treatment of atopic dermatitis: a meta-analysis of randomized controlled trials. Ann Allergy, Asthma Immunol 2014; 11(3): 217-26.
Rather IA, Bajpai VK, Kumar S, Lim J, Paek WK, Park YH. Probiotics and atopic dermatitis: an overview. Front Microbiol 2016; 7: 507-14.
Kalliomaki M, Antoine JM, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. The Journal of nutrition 2015; 715-21.
Prakoeswa CRS, Herwanto N, Prameswari R, Astari L, Sawitri, Hidayati AN, et al. Lactobacillus plantarum IS-10506 supplementation reduced SCORAD in children with atopic dermatitis. Benef Microbes 2017; 8(5): 833-40.
Iemoli E, Trabattini D, Parisotto S, Borgonovo L, Toscano M. Probiotics reduce gut microbial translocation and improve adult atopic dermatitis. J Clin Gastroenterol 2012; 46(1): 36-40.
James WD, Berger TG, Elston DM, Neuhaus IM. Atopic dermatitis, eczema, and noninfectious immunodeficiency disorders. In: James WD, Berger TG, Elston DM, Neuhaus IM. Andrew's diseases of the skin. 12th ed. Philadelphia: Elsevier, 2016.p.62-89.
Inoue Y, Kambara T, Murata N, Yamaguchi JK, Matsukura S, Takahashi Y, et al. Effects of oral administration of lactobacillus acidophilus l-92 on the symptoms and serum cytokines of atopic dermatitis in japanese adults: a double-blind, randomized, clinical trial. Int Arch Allergy Immunol 2014; 165:247–54.
Yoshida Y, Seki T, Matsunaka H, Watanabe T, Shindo M, Yamada N, et al. Clinical effect of probiotic Bifidobacterium breve supplementation in adult with atopic dermatitis. Yonago Acta Med 2010; 53:37-45.
Rubel D, Thirumoorthy, Soebaryo RW, Weng SCK, Gabriel TM, Villafuerte LL, et al. Consensus guidelines for management of atopic dermatitis: an Asia-Pasifik perspective. J Dermatol 2013; 40 (3): 160-71.
Nutten S. Atopic dermatitis: global epidemiology and risk factors. Ann Nutr Metab 2015; 66(suppl 1): 8-16.
Kim HW, Rira H, Eun YC, Keeshun Yu, Narae Kim. A probiotic mixture regulates T Cell balance and reduces atopic dermatitis symptoms. Front Microbiol 2018; 9: 2414-19.
- Copyright of the article is transferred to the journal, by the knowledge of the author, whilst the moral right of the publication belongs to the author.
- The legal formal aspect of journal publication accessibility refers to Creative Commons Atribusi-Non Commercial-Share alike (CC BY-NC-SA), (https://creativecommons.org/licenses/by-nc-sa/4.0/)
- The articles published in the journal are open access and can be used for non-commercial purposes. Other than the aims mentioned above, the editorial board is not responsible for copyright violation
The manuscript authentic and copyright statement submission can be downloaded ON THIS FORM.